We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$2.3B
AUM Growth
+$247M
Cap. Flow
+$141M
Cap. Flow %
6.12%
Top 10 Hldgs %
17.75%
Holding
321
New
26
Increased
135
Reduced
107
Closed
32

Top Buys

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$27M
2
REVG
REV Group
REVG
+$18.6M
3
DBD
Diebold Nixdorf Incorporated
DBD
+$17.2M
4
WGO icon
Winnebago Industries
WGO
+$10.7M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$9.54M

Top Sells

Rank Stock Value
1
CEB
CEB Inc.
CEB
+$22.7M
2
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$20.1M
3
HELE icon
Helen of Troy
HELE
+$20M
4
ALOG
Analogic Corp
ALOG
+$18.5M
5
AMRI
Albany Molecular Research Inc
AMRI
+$17.3M

Sector Composition

Rank Sector Weight
1 Healthcare 20.64%
2 Technology 18.67%
3 Industrials 18.25%
4 Consumer Discretionary 13.65%
5 Financials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTMD icon
276
Utah Medical Products
UTMD
$230M
$277K 0.01%
3,829
+40
+1% +$2.63K
BMY icon
277
Bristol-Myers Squibb
BMY
$135B
$267K 0.01%
4,788
-800
-14% -$43.5K
FTK icon
278
Flotek Industries
FTK
$1.02B
$267K 0.01%
+4,969
New +$313K
MEET
279
DELISTED
The Meet Group, Inc. Common Stock
MEET
$264K 0.01%
52,360
+539
+1% +$2.8K
XEL icon
280
Xcel Energy
XEL
$48.6B
$261K 0.01%
5,693
-304
-5% -$14K
WDFC icon
281
WD-40
WDFC
$3.17B
$259K 0.01%
2,350
– –
ADI icon
282
Analog Devices
ADI
$185B
$239K 0.01%
3,070
– –
EXPE icon
283
Expedia Group
EXPE
$37.5B
$235K 0.01%
1,580
+150
+10% +$21.1K
AAPL icon
284
Apple
AAPL
$4.52T
$205K 0.01%
5,700
– –
LLY icon
285
Eli Lilly
LLY
$995B
$205K 0.01%
2,490
– –
DENN
286
DELISTED
Denny's
DENN
$189K 0.01%
16,066
+161
+1% +$1.93K
JPM icon
287
JPMorgan Chase
JPM
$950B
$188K 0.01%
+2,058
New +$178K
ATTU
288
DELISTED
Attunity Ltd
ATTU
$143K 0.01%
19,938
-137,270
-87% -$1.02M
SPWH icon
289
Sportsman's Warehouse
SPWH
$44.9M
$77K ﹤0.01%
14,250
+113
+0.8% +$569
ANIP icon
290
ANI Pharmaceuticals
ANIP
$1.8B
– –
-32,426
Closed -$1.6M
CATY icon
291
Cathay General Bancorp
CATY
$4.3B
– –
-440,873
Closed -$16.6M
CBRE icon
292
CBRE Group
CBRE
$43.7B
– –
-32,077
Closed -$1.12M
EPD icon
293
Enterprise Products Partners
EPD
$82.5B
– –
-7,280
Closed -$201K
FCN icon
294
FTI Consulting
FCN
$4.34B
– –
-396,492
Closed -$16.3M
GCO icon
295
Genesco
GCO
$439M
– –
-13,026
Closed -$722K
GWW icon
296
W.W. Grainger
GWW
$61.4B
– –
-990
Closed -$230K
HAE icon
297
Haemonetics
HAE
$3.88B
– –
-117,978
Closed -$4.79M
HELE icon
298
Helen of Troy
HELE
$658M
– –
-212,542
Closed -$20M
ICFI icon
299
ICF International
ICFI
$1.56B
– –
-66,869
Closed -$2.76M
ICUI icon
300
ICU Medical
ICUI
$4.3B
– –
-3,713
Closed -$567K
9 10 11
12
13

Similar funds

GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
EFS
Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return
OAM
Ostrum Asset Management Paris, France $1.78B AUM 27.8% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $1.78B AUM 22.52% 1-Year Est. Return
BCMIO
Beacon Capital Management Inc (Ohio) Dayton, Ohio $1.78B AUM 14.7% 1-Year Est. Return

Rice Hall James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Rice Hall James & Associates held 321 positions worth $2.3B, up 12% from $2.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Rice Hall James & Associates deployed $141M of net new capital in Q2 2017, opening 26 new positions and adding to 135 existing holdings. Its largest new stake was Acadia Healthcare: 610,592 shares worth $30.2M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Advanced Energy, an estimated $6.38M trimmed.

  • Rice Hall James & Associates's largest Q2 2017 buy was Acadia Healthcare: 610,592 shares worth $30.2M.
  • Rice Hall James & Associates added most to Supernus Pharmaceuticals in Q2 2017, an estimated $9.54M increase.
  • Rice Hall James & Associates's biggest Q2 2017 reduction was Advanced Energy, cutting an estimated $6.38M.
  • Rice Hall James & Associates fully exited CEB Inc. in Q2 2017, selling an estimated $22.7M.
  • Rice Hall James & Associates's ten largest holdings make up 18% of its $2.3B portfolio in Q2 2017.
  • Rice Hall James & Associates opened 26 new positions and closed 32 in Q2 2017.
  • Rice Hall James & Associates's portfolio value rose 12% quarter-over-quarter to $2.3B.

Based on Rice Hall James & Associates's 13F filing for Q2 2017, filed 2 Aug 2017.